SkyAI, Inc.
Melville, New York, United States · Community And Lifestyle, Health Care, Information Technology
Sharps Technology, Inc. is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through innovation. Sharps line of smart safety syringes that eliminate accidental needlestick injuries, prevent needle reuse, and reduce wasted medicine and vaccines—while retaining the intuitive simplicity of traditional syringes.
Key facts
- Headquarters
- Melville, New York, United States
- Employees
- 55
- Industries
- Community And Lifestyle, Health Care, Information Technology
- Status
- Public (SKYA)
- Website
- sharpstechnology.com
- Company page
Recent activity at SkyAI, Inc.
- : SEC 8-K (1.01): On October 27, 2026, SkyAI, Inc. entered into a tender offer support and settlement agreement with Bastion Trading Limited and its affiliates. The Agreement modifies the ongoing cash tender offer by allowing the tendering of 100% of both cash and cryptocurrency pre-funded warrants, introduces cash and cryptocurrency stapled warrants into the Offer priced at $0.17 each, and extends the Offer's term to at least November 12, 2026. Additionally, Bastion agrees to tender all beneficially owned securities and adhere to a three-year standstill period preventing them from acquiring more than 5% of the Company's securities without Board approval. This strategic agreement is expected to enhance the Offer's attractiveness to stakeholders and navigate regulatory considerations regarding payment withholdings for non-U.S. holders.
- : SEC 8-K (8.01): On October 19, 2026, SkyAI, Inc. announced the commencement of a tender offer dated October 16, 2026, aimed at purchasing up to 95% of its outstanding common stock and several types of warrants at a price of $3.00 per share or warrant in cash. This strategic offer is designed to increase shareholder value and strengthen its financial position. The details of the offer, including terms and conditions, are outlined in the Offer to Purchase and related materials filed with the SEC. The announcement includes significant information for investors considering whether to tender their shares or warrants in this offer.
- : SEC 8-K (8.01): On October 14, 2026, SkyAI, Inc. announced its plans to launch a tender offer on October 15, 2026. The tender offer, aimed at buying shares, cash pre-funded warrants, and cryptocurrency pre-funded warrants, has not yet commenced and is subject to the filing of a tender offer statement on Schedule TO with the SEC. This announcement outlines significant strategic moves for the company in the financial technology sector, integrating stablecoin operations with AI technology. Investors are advised to consult the detailed offer materials once they are available, as they will contain essential information regarding the terms and conditions of the Offer.
- : SEC 8-K (8.01): On October 11, 2026, SkyAI, Inc. announced its intention to commence a cash tender offer to purchase up to 95% of its outstanding common stock and related securities at a price of $3.00 per share. The Offer is expected to commence on or about October 15, 2026, and will last for 10 business days unless extended or terminated. The Offer is contingent upon a minimum of 50% of each class being validly tendered and the price of SOL remaining above $100 during the Offer period. As of now, SKYAI retains approximately 600,000 SOL and has 80% of the cash required for the Offer, reflecting strategic financial planning in a volatile market.
- : SEC 8-K (8.01): SkyAI, Inc., a Nevada corporation, filed an 8-K to disclose the formation of a Special Committee by its Board of Directors to evaluate an unsolicited, non-binding proposal from Forward Industries, Inc. regarding a potential all-stock business combination. After thorough review, both the Special Committee and the Board unanimously determined that the proposal was not in the best interests of shareholders and that the Company is not pursuing the transaction at this time. The filing date is July 17, 2026, indicating a proactive governance approach towards potentially impactful proposals.
- : SEC 8-K (8.01):
- : SEC 8-K (5.02):
- : SEC 8-K (5.02): On February 17, 2026, Sharps Technology, Inc. appointed Arthur Levine as interim Chief Financial Officer under a fee agreement with DLA, LLC, effective for an initial term of three months. The company will compensate Mr. Levine at a rate of $450 per hour. Arthur Levine has a significant background as he previously served as CFO for NextNRG, Inc. and Sensus Healthcare, showcasing his experience in financial leadership. The appointment is part of the company's strategy to ensure continuity in financial management while searching for a permanent CFO, and it aligns with customary indemnification practices as the company has also executed an indemnification agreement effective the same day, February 17, 2026.
- : SEC 8-K (8.01): On January 15, 2026, Sharps Technology, Inc. established three new Board Committees: the Audit Committee, Compensation Committee, and Nominating Committee, with their respective charters being adopted. The Audit Committee Charter, Compensation Committee Charter, and Nominating Committee Charter are detailed in Exhibit 99.1, Exhibit 99.2, and Exhibit 99.3 respectively. The adoption of these charters signifies a strategic enhancement of governance and oversight within the company, reflecting its commitment to strong corporate governance practices. The establishment of these committees is expected to provide structured governance and improved decision-making capabilities within the company as it moves forward.
- : SEC 8-K (1.01): On January 15, 2026, Sharps Technology, Inc. entered into a lock-up agreement with Sol Markets, a Cayman Islands exempt company. This agreement restricts the Strategic Advisor from offering, selling, or otherwise disposing of any shares of common stock of Sharps for 90 days from the agreement date. The transaction aims to stabilize the company's stock following recent events. The terms of the agreement are outlined in the attached Exhibit 10.1.
SkyAI, Inc. funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Venture | $410.9M |
| Aug 2025 | Post-IPO Equity | $400.0M |
| May 2019 | Venture | $2.8M |
| May 2018 | Venture | $425K |
Leadership
- Barry Berler, Founder Inventor & CTO
- Tony Mulone, Director
- David Loewenstein, Director
- Alan Blackman, Executive Officer, Director
- Braden Miller, Vice President
- Frank Parrado, VP of Finance
- Andrew Crescenzo, Chief Financial Officer
- Robert Hayes, Chief Executive Officer
- Alice Zhang, Chief Investment Officer
- Robert Hayes, Chief Executive Officer
- Andrew Crescenzo, Chief Financial Officer
- George Cagna, Executive Officer
Verified email and direct lines for SkyAI, Inc.’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
SkyAI, Inc. files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
SkyAI, Inc. in the news
- ️ LATEST: SkyAI, formerly Sharps Technology, has officially - KuCoin (Oct 20, 2026)
- SkyAI sells off entire Solana treasury as it launches $201 million buyback - The Block (Oct 19, 2026)
- SkyAI (Nasdaq:SKYA) - Stock Analysis - Simply Wall St (Oct 03, 2026)
- SkyAI, Inc. Common Stock (SKYA) Stock Price, News & Analysis - MarketBeat (Aug 15, 2021)
Companies similar to SkyAI, Inc.
- Zimmer · Health Care, Information Technology, Manufacturing, Medical, medical devices
- MedShift · Health Care, Information Technology, Manufacturing, Medical
- Andersen Sterilizers · Health Care, Manufacturing, Medical, medical devices
- IceCure Medical · Health Care, Manufacturing, Medical, medical devices
- Third Pole · Health Care, Information Technology, Manufacturing, Medical
About SkyAI, Inc.: questions and answers
What does SkyAI, Inc. do?
Sharps Technology, Inc. is a medical device company addressing global issues while engineering a safer future for healthcare providers and people everywhere through innovation. Sharps line of smart safety syringes that eliminate accidental needlestick injuries, prevent needle reuse, and reduce wasted medicine and vaccines—while retaining the intuitive simplicity of traditional syringes.
Where is SkyAI, Inc. headquartered?
SkyAI, Inc. is headquartered in Melville, New York, United States.
How many employees does SkyAI, Inc. have?
SkyAI, Inc. has about 55 employees.
Has SkyAI, Inc. raised funding?
Yes. Fundz has recorded 4 funding events for SkyAI, Inc.. The most recent, $410.9M, was in Oct 2025.
Who leads SkyAI, Inc.?
Barry Berler is a Founder Inventor & CTO at SkyAI, Inc..
What is the latest news on SkyAI, Inc.?
On Oct 28, 2026, SEC 8-K (1.01): On October 27, 2026, SkyAI, Inc. entered into a tender offer support and settlement agreement with Bastion Trading Limited and its affiliates. The Agreement modifies the ongoing cash tender offer by allowing the tendering of 100% of both cash and cryptocurrency pre-funded warrants, i
Is SkyAI, Inc. a public company?
Yes. SkyAI, Inc. is publicly traded under the ticker SKYA.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy